Unknown OBSERVATIONAL NCT04326387

Evaluation of Novel Diagnostic Tests for COVID-19 (COVIDx)

Evaluation of Novel Diagnostic Tests for 2019-nCOV

Sponsor: CCTU- Cancer Theme

Conditions Acute Disease Coronavirus Respiratory Viral Infection

Interventions Cambridge Validated Viral Detection Method Public Health England Gold Standard Radiological Detection SAMBA II (Diagnostic for the Real World)

Updated 9 times since 2020 Last updated: May 15, 2020 Started: Apr 6, 2020 Primary completion: Apr 7, 2021 Completion: Oct 7, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Disease and Coronavirus and is currently ongoing. CCTU- Cancer Theme leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Jun 2022 [monthly]

Recruiting
Jan 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 4 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
Jun 2020 — Nov 2020 [monthly]

Recruiting
May 2020 — Jun 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Apr 2020 — May 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CCTU- Cancer Theme

Data source: Cambridge University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cambridge, United Kingdom